Equifax, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Buy

52

EFX
Equifax, Inc.

Last Price:

$218.18

Seasonality Move:

5.51%

Sell

42

NKTR
Nektar Therapeutics

Last Price:

$45.42

Seasonality Move:

11.58%

Buy

52

Equifax, Inc. (EFX) is a Buy

Is Equifax, Inc. a Buy, Sell or Hold?

The current Equifax, Inc. [EFX] share price is $218.53. The Score for EFX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
EFX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

42

Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EFX Stock Price Chart

What is Equifax, Inc.'s stock price today?

The Equifax, Inc. share price today is $218.53

The current trend is relatively stagnant and EFX is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

The Nektar Therapeutics share price today is $49.16

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

EFX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.48	Buy
Relative Strength Index (14 RSI):	56.18	Buy
Chaikin Money Flow:	709243	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(206.8 - 215.78)	Buy
Bollinger Bands (100):	(214.66 - 250.46)	Sell

NKTR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.43	Sell
Relative Strength Index (14 RSI):	38.92	Sell
Chaikin Money Flow:	341847	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(53.73 - 61.13)	Sell
Bollinger Bands (100):	(33.63 - 62.73)	Buy

EFX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	215.37	Buy
20-day SMA:	212.12	Buy
50-day SMA:	217.09	Buy
200-day SMA:	242.62	Sell
8-day EMA:	216.15	Buy
20-day EMA:	214.06	Buy
50-day EMA:	219.25	Sell
200-day EMA:	238.79	Sell

NKTR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	54.87	Sell
20-day SMA:	57.43	Sell
50-day SMA:	58.05	Sell
200-day SMA:	31.04	Buy
8-day EMA:	54.11	Sell
20-day EMA:	56.28	Sell
50-day EMA:	55.42	Sell
200-day EMA:	38.13	Buy

Equifax, Inc. Earnings Growth & EFX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and an increase next year of $1.23 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Equifax, Inc. Technical Analysis

	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16
	Dec
	03	04	05	08	09	10	11	12	15	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16
	Dec
	03	04	05	08	09	10	11	12	15	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):